Retinal prosthesis improves visual performance of spatial motor tasks

Article

Artificial vision provided by the Argus II retinal prosthesis strengthens vision in spatial motor tasks, according to findings published in the British Journal of Ophthalmology.

Artificial vision provided by the Argus II retinal prosthesis strengthens vision in spatial motor tasks, according to findings published in the British Journal of Ophthalmology.

A study led by Dr Ashish K. Ahuja, Sight Medical Products, Sylmar, California, USA, involved 27 participants implanted with the Argus II retinal prosthesis. A 19 inch touch screen was used to display high-contrast square stimuli. The square appeared at random locations on the screen and participants were told to touch the square when it was present and then again when it disappeared. The coordinates of the square's centre were recorded.

Of the 27 eyes examined, 26 demonstrated a significant improvement in accuracy and 25 eyes demonstrated significant improvement in repeatability of results. In the group, 4 subjects showed a significant improvement in both repeatability and accuracy.

Argus II retinal prosthesis is successful in significantly improving performance in spatial motor-tasks.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.